EUVIMEDEUVIMED entdecken
Open Access

Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk

Yijia Sun, Timothy Simmons, James L Li, Armaan Jamal, Achille V C Manirakiza, Dmitry Pruss, Sarah Ratzel, Olufunmilayo I Olopade, Alexander Gutin, Elisha Hughes, Dezheng Huo

JAMA Network Open · 17.06.2026 · 9 (6) · e2619285

DOI: 10.1001/jamanetworkopen.2026.19285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.06.2026. Verfasst von Yijia Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Black or African American, Breast Neoplasms, Genetic Risk Score. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Validating polygenic risk scores (PRSs) as a breast cancer (BC) risk stratification tool in high-risk clinical settings is essential for potential clinical implementation.

Objective

To evaluate the performance of African-ancestry PRSs for overall BC and triple-negative BC (TNBC) in an independent African American cohort at elevated familial risk. Design, Setting, and Participants This case-control study was conducted among women with self-reported African ancestry in a clinical hereditary cancer genetic testing setting who had negative results for pathogenic or likely pathogenic variants in known BC-associated genes between 2016 to 2024. Analyses were performed from September 2025 to April 2026. Exposure Six African-ancestry PRSs and a European-ancestry PRS (PRS-313). Main Outcomes and Measures Performance of the PRSs was measured with covariate-adjusted area under the receiver operating characteristic curve (AUC) and adjusted odds ratio (OR) per 1 SD from logistic regression adjusting for age, top 10 genetic principal components, and family history.

Results

This study included 31 522 women (mean [SD] age, 47.1 [13.3] years): 12 067 women with BC (2311 with TNBC) and 19 455 women unaffected by BC. Women unaffected by BC were younger at testing than women with BC at diagnosis (mean [SD] age, 42.1 [11.7] years vs 55.2 [11.8] years) and were more likely to report a first- and second-degree family history of BC than women with BC (14 524 women [74.7%] vs 6483 women [53.7%]). For overall BC, PRS-313 showed an AUC of 0.567 (95% CI, 0.560-0.574) and an OR of 1.28 (95% CI, 1.25-1.31) per 1 SD of individuals unaffected by BC. In comparison, the African overall BC models 1 (2 324 063-variant model) and 2 (175 173-variant model) performed better, with AUCs of 0.588 (95% CI, 0.580-0.595) and 0.584 (95% CI, 0.576-0.591) and ORs of 1.39 (95% CI, 1.35-1.43) and 1.37 (95% CI, 1.34-1.41) per 1 SD of individuals unaffected by BC, respectively. Importantly, for TNBC, one 162-variant PRS consistently outperformed all other models, with an AUC of 0.609 (95% CI, 0.596-0.622) and an OR of 1.47 (95% CI, 1.40-1.55) per 1 SD of individuals unaffected by BC. Conclusions and Relevance In this clinically ascertained case-control study of self-reported Black or African American women, the PRSs demonstrated good performance among women with a strong family history of BC, reflecting populations in whom early PRS testing is most relevant. The high accuracy of the 162-variant TNBC PRS supported its potential as a cost-effective risk assessment tool to promote equitable care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanBreast NeoplasmsGenetic Risk ScoreAdultFemaleHumansMiddle AgedCase-Control StudiesRisk Assessment

Autor:innen und Institutionen

  • Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
  • Myriad Genetics, Inc, Salt Lake City, Utah.
  • Interdisciplinary Scientist Training Program, University of Chicago, Chicago, Illinois.
  • Center for Innovation in Global Health, University of Chicago, Chicago, Illinois.
  • Oncology Service, Department of Medicine, King Faisal Hospital Rwanda, Africa Health Sciences University, Kigali, Rwanda.

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Sun, Y., Simmons, T., Li, J. L., Jamal, A., Manirakiza, A. V. C., Pruss, D., Ratzel, S., Olopade, O. I., Gutin, A., Hughes, E., & Huo, D. (2026). Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk. JAMA Network Open, 9(6), e2619285. https://doi.org/10.1001/jamanetworkopen.2026.19285

Vancouver

Sun Y, Simmons T, Li JL, Jamal A, Manirakiza AVC, Pruss D, et al. Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk. JAMA Network Open. 2026;9(6):e2619285. doi:10.1001/jamanetworkopen.2026.19285

BibTeX
@article{Sun2026,
  author = {Sun, Yijia and Simmons, Timothy and Li, James L and Jamal, Armaan and Manirakiza, Achille V C and Pruss, Dmitry and Ratzel, Sarah and Olopade, Olufunmilayo I and Gutin, Alexander and Hughes, Elisha and Huo, Dezheng},
  title = {Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {6},
  pages = {e2619285},
  doi = {10.1001/jamanetworkopen.2026.19285}
}
Kostenlos starten →